Israeli biotech Kitov has announced that it will be ready at the end of 2016 to launch its treatment for osteoarthritis pain and hypertension simultaneously; The BBC has just reported that the UK’s National Health Service has approved the funding of patients receiving the pioneering melanoma treatment developed by Israeli Professor Jacob Schachter, and much more.
By: Michael Ordman
ISRAEL’S MEDICAL ACHIEVEMENTS
Osteoarthritis pain and hypertension treatment by end of year
Israeli biotech Kitov has announced that it will be ready at the end of 2016 to launch its KIT-302 treatment for osteoarthritis pain and hypertension simultaneously. Dexcel will mass-produce and market the treatment.
UK NHS funds melanoma treatment using Israeli discovery
The BBC has just reported that the UK’s National Health Service has approved the funding of patients receiving the pioneering melanoma (skin cancer) treatment developed by Israeli Professor Jacob Schachter. The approval was one of the fastest in NHS history. The anti-Israel BBC doesn’t mention the Israeli connection, so please read Sheba hospital’s article for details.
75% reduction in added surgery
Surgeons at Mercy Medical Center at Cedar Rapids, Iowa, have reported that MarginProbe from Israel’s Dune Medical has reduced the number of repeat breast-cancer operations by 75%. MarginProbe checks accurately that all cancerous tissue has been removed first time.
Digital Health incubator is launched
IBM, Medtronic, Pitango and Rambam Medical Center planned a digital medicine incubator at the Life Sciences Park being built in Haifa. “MindUP” is up and running, and ready to build technologies to improve the quality and efficiency of healthcare delivery.
An ingredient to win your heart
The supplement Cardiomato, from Israel’s Lycored, beat hundreds of high-quality competitor products to win the NutraIngredients Award for Best Finished Product of the Year – Heart Health. Cardiomato reduces oxidized LDL cholesterol and lowers systolic blood pressure.
What will they print next?
Israeli research into bio-ink could potentially print human organs. Now two Israeli companies, Nano Dimension and Accelta have successfully lab-tested a proof-of-concept 3D bio-printer. It may even be able to print stem cells!
ALS solution wins $32k from public votes
The communication device for ALS and other “Locked in” patients from Israel’s EyeControl, reached the final in the on-line competition “The Venture”. The public voted $32,683 of the $250,000 prize fund to EyeControl – the second highest of the 27 finalists (from 3000 entries).
Microsoft health analytics conference
Microsoft’s Israeli Research & Development Center in Herzliya is the venue for the company’s first ever health analytics conference on Jun 22. Subjects include Internet data, wearables, big data and IBM Watson,
Sleep scientist wins $100,000 prize
The Adelis Award for groundbreaking research by a young scientist has been presented to Dr. Yuval Nir of Tel Aviv University for his work in the field of sleep. The $100,000 award aims to encourage excellence among young Israeli scientists performing brain research in Israel.
Click here for all of this week’s Good News from Israel.